ADICET BIO INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period	2023	2022	2021	2020	2019	2018	2017
Period End Date	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Revenue-related party	--	24.99	9.73	17.90	--	--	--
Total Revenues	--	24.99	9.73	17.90	--	--	--
Goodwill impairment	19.46	--	--	--	--	--	--
Research and development	106.04	71.25	48.94	34.33	73.63	31.07	16.84
General and Administrative	26.53	26.30	22.22	22.76	11.82	8.64	2.04
Total Operating Expenses	152.04	97.54	71.16	57.09	85.46	39.71	18.88
Loss from operations	(152.04)	(72.55)	(61.43)	(39.19)	(85.46)	(39.71)	(18.88)
Interest expense	0.03	0.08	0.18	0.13	--	--	--
Interest income	9.98	3.76	0.09	0.79	2.82	--	--
Other expense, net	(0.57)	(0.92)	(0.61)	(0.95)	(0.06)	2.12	(14.90)
LOSS BEFORE INCOME TAXES	(142.66)	(69.79)	(62.12)	(39.49)	(82.70)	(37.59)	(33.78)
Income tax expense	--	--	(0.13)	(2.82)	0.04	0.03	0.00
Net Income (Loss) Available to Common Shareholders	(142.66)	(69.79)	(62.00)	(36.68)	(82.74)	(37.61)	(33.78)
Net Earnings per share-Basic	(3.31)	(1.70)	(2.00)	(5.01)	(16.86)	(9.94)	(58.92)
Net Earnings per share-Diluted	(3.31)	(1.70)	(2.00)	(5.01)	(16.86)	(9.94)	(58.92)
Weighted average shares outstanding-Basic	43.04	41.08	30.95	7.32	4.90	3.78	0.57
Weighted average shares outstanding-Diluted	43.04	41.08	30.95	7.32	4.90	3.78	0.57